489 related articles for article (PubMed ID: 19390314)
21. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
Leahy Y
Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
[TBL] [Abstract][Full Text] [Related]
22. Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.
Schellong G; Riepenhausen M
Klin Padiatr; 2004; 216(6):364-9. PubMed ID: 15565552
[TBL] [Abstract][Full Text] [Related]
23. Radiation-associated cardiovascular disease: manifestations and management.
Adams MJ; Lipshultz SE; Schwartz C; Fajardo LF; Coen V; Constine LS
Semin Radiat Oncol; 2003 Jul; 13(3):346-56. PubMed ID: 12903022
[TBL] [Abstract][Full Text] [Related]
24. Late effects of radiation therapy in the treatment of Hodgkin's disease.
Kinsella TJ; Fraass BA; Glatstein E
Cancer Treat Rep; 1982 Apr; 66(4):991-1001. PubMed ID: 6804091
[TBL] [Abstract][Full Text] [Related]
25. Secondary lung tumors in hematological patients.
Amadori D; Ronconi S
Semin Respir Crit Care Med; 2005 Oct; 26(5):520-6. PubMed ID: 16267703
[TBL] [Abstract][Full Text] [Related]
26. Rare, late complications in a patient with Hodgkin's disease.
Illés A; Gergely L; Miltényi Z; Keresztes K; Olvasztó S; Redl P; Dankó K
Haematologia (Budap); 2002; 32(4):509-18. PubMed ID: 12803127
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in people with Hodgkin's disease.
Yellen SB; Cella DF; Bonomi A
Oncology (Williston Park); 1993 Aug; 7(8):41-5; discussion 46, 50-2. PubMed ID: 8398634
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
[TBL] [Abstract][Full Text] [Related]
30. Role of the primary care physician in Hodgkin lymphoma.
Glass C
Am Fam Physician; 2008 Sep; 78(5):615-22. PubMed ID: 18788239
[TBL] [Abstract][Full Text] [Related]
31. Role of radiation therapy in Hodgkin's lymphoma.
Yahalom J
Cancer J; 2009; 15(2):155-60. PubMed ID: 19390312
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin lymphoma: the follow-up of long-term survivors.
Hodgson DC
Hematol Oncol Clin North Am; 2008 Apr; 22(2):233-44, vi. PubMed ID: 18395147
[TBL] [Abstract][Full Text] [Related]
33. [Late side-effects are common after treatment of Hodgkin's disease. Muscular atrophy following radiotherapy is a neglected risk].
Johansson AS; Erlanson M; Lenner P; Lindh J; Osterman B
Lakartidningen; 1998 Jan; 95(1-2):44-7. PubMed ID: 9458645
[TBL] [Abstract][Full Text] [Related]
34. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease.
van Leeuwen-Segarceanu EM; Bos WJ; Dorresteijn LD; Rensing BJ; der Heyden JA; Vogels OJ; Biesma DH
Cancer Treat Rev; 2011 Aug; 37(5):391-403. PubMed ID: 21333452
[TBL] [Abstract][Full Text] [Related]
35. Subsequent malignant neoplasms in cancer survivors.
Ng AK; Travis LB
Cancer J; 2008; 14(6):429-34. PubMed ID: 19060610
[TBL] [Abstract][Full Text] [Related]
36. Proceedings: Hodgkin's disease. Five years' experience of a combined haemic-lymphatic clinic.
Ewing DP; Rozenberg MC; Freedman A; Grace CS; Lam-Po-Tang PR
Med J Aust; 1974 Jul; 2(4):128-32. PubMed ID: 4419384
[No Abstract] [Full Text] [Related]
37. Cardiovascular late effects.
Greving DM; Santacroce SJ
J Pediatr Oncol Nurs; 2005; 22(1):38-47. PubMed ID: 15574725
[TBL] [Abstract][Full Text] [Related]
38. Emerging drugs for Hodgkin's lymphoma.
Böll B; Borchmann P; Diehl V
Expert Opin Emerg Drugs; 2010 Dec; 15(4):585-95. PubMed ID: 20629601
[TBL] [Abstract][Full Text] [Related]
39. Late effects of pediatric cancer treatment come into sharper focus, predictive tests are emerging.
McNeil C
J Natl Cancer Inst; 2006 Jul; 98(13):882-4. PubMed ID: 16818847
[No Abstract] [Full Text] [Related]
40. New strategies for the treatment of early stages of Hodgkin's lymphoma.
Macdonald DA; Connors JM
Hematol Oncol Clin North Am; 2007 Oct; 21(5):871-80. PubMed ID: 17908625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
